Conclusion: In this study, we demonstrate that HSC-specific deletion of ETS1 exacerbates liver fibrosis and suppresses fibrosis regression
Results show that GLP-1RA users, defined as individuals with a history of use exceeding six months and with at least two refills within six months prior to the procedure, experienced a higher incidence rate of aspiration pneumonia (0.83%) compared to nonusers (0.63%), corresponding to a hazard ratio of 1.33
Why GLP-1 Medications Are Reshaping Weight Loss These medications were originally developed for patients with type 2 diabetes, but their effects on appetite regulation, insulin sensitivity and inflammation quickly pushed them into the spotlight for weight loss
124,125,126 The design concept of these multi-agonists is to simultaneously regulate multiple key metabolic pathways to achieve more effective control over blood sugar, body weight, and overall metabolic health
The more responsible approach is to address the systems that actually shape brain aging: metabolic health, cardiovascular risk, sleep, movement, body composition, inflammation, sensory health, hormones, nutrition, and long-term function